Anti-ATM抗体[Y170] (ab32420)

ab32420 被引用在 27 文献中.

• Feng X  et al. Low Ki67/high ATM protein expression in malignant tumors predicts favorable prognosis in a retrospective study of early stage hormone receptor positive breast cancer. Oncotarget 7:85798-85812 (2016). IHC ; Human . PubMed: 27741524
• Zhang H  et al. Loss of H3K9me3 Correlates with ATM Activation and Histone H2AX Phosphorylation Deficiencies in Hutchinson-Gilford Progeria Syndrome. PLoS One 11:e0167454 (2016). WB, ICC/IF ; Human . PubMed: 27907109
• Hu JL  et al. Abnormal Expression of DNA Double-Strand Breaks Related Genes, ATM and GammaH2AX, in Thyroid Carcinoma. Int J Endocrinol 2015:136810 (2015). IHC ; Human . PubMed: 25861265
• Feng X  et al. Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer. Breast Cancer Res 17:65 (2015). IHC ; Human . PubMed: 25935535
• Abdel-Fatah TM  et al. Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts. Neoplasia 16:982-91 (2014). IHC ; Human . PubMed: 25425972
• Lu H  et al. Senescence induced by RECQL4 dysfunction contributes to Rothmund-Thomson syndrome features in mice. Cell Death Dis 5:e1226 (2014). WB ; Human . PubMed: 24832598
• Kim H  et al. Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis. Clin Cancer Res 20:1865-72 (2014). IHC-P ; Human . PubMed: 24486587
• Carlessi L  et al. Functional and molecular defects of hiPSC-derived neurons from patients with ATM deficiency. Cell Death Dis 5:e1342 (2014). WB ; Human . PubMed: 25032865
• Li WF  et al. WISP-1 contributes to fractionated irradiation-induced radioresistance in esophageal carcinoma cell lines and mice. PLoS One 9:e94751 (2014). PubMed: 24728101
• Kim HS  et al. Mutation at intronic repeats of the ataxia-telangiectasia mutated (ATM) gene and ATM protein loss in primary gastric cancer with microsatellite instability. PLoS One 8:e82769 (2013). IHC-P ; Human . PubMed: 24324828
• Cesare AJ  et al. The telomere deprotection response is functionally distinct from the genomic DNA damage response. Mol Cell 51:141-55 (2013). Human . PubMed: 23850488
• Lundholm L  et al. Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest. Cell Death Dis 4:e478 (2013). WB ; Human . PubMed: 23370278
• Zhang ZZ  et al. Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma. World J Gastroenterol 19:1968-74 (2013). IHC-P ; Human . PubMed: 23569343
• Gautam D & Bridge E The kinase activity of ataxia-telangiectasia mutated interferes with adenovirus E4 mutant DNA replication. J Virol 87:8687-96 (2013). PubMed: 23740981
• Butin-Israeli V  et al. Regulation of nucleotide excision repair by nuclear lamin b1. PLoS One 8:e69169 (2013). WB ; Human . PubMed: 23894423
• Köcher S  et al. ATM is required for the repair of Topotecan-induced replication-associated double-strand breaks. Radiother Oncol N/A:N/A (2013). WB ; Human . PubMed: 23928469
• Yajima H  et al. The complexity of DNA double strand breaks is a critical factor enhancing end-resection. DNA Repair (Amst) 12:936-46 (2013). WB ; Human . PubMed: 24041488
• Hu S  et al. Nuclear survivin and its relationship to DNA damage repair genes in non-small cell lung cancer investigated using tissue array. PLoS One 8:e74161 (2013). IHC-P ; Human . PubMed: 24066112
• Freund A  et al. Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell 23:2066-75 (2012). WB ; Human . PubMed: 22496421
• Knappskog S  et al. Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer. Breast Cancer Res 14:R47 (2012). IHC-P ; Human . PubMed: 22420423
• Geng L  et al. Checkpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil. PLoS One 6:e28862 (2011). WB . PubMed: 22194930
• Shkreta L  et al. The DNA Damage Response Pathway Regulates the Alternative Splicing of the Apoptotic Mediator Bcl-x. J Biol Chem 286:331-40 (2011). WB ; Human . PubMed: 20980256
• Sánchez-Molina S  et al. Role for hACF1 in the G2/M damage checkpoint. Nucleic Acids Res : (2011). WB ; Human . PubMed: 21745822
• Kadaja M  et al. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog 5:e1000397 (2009). ICC/IF ; Human . PubMed: 19390600
• Jiang H  et al. The combined status of ATM and p53 link tumor development with therapeutic response. Genes Dev 23:1895-909 (2009). IHC-P ; Human . PubMed: 19608766
• Rodier F  et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 11:973-9 (2009). WB ; Human . PubMed: 19597488
• Skaar JR  et al. INTS3 controls the hSSB1-mediated DNA damage response. J Cell Biol 187:25-32 (2009). WB ; Human . PubMed: 19786574